Robert T. OʼDonnell

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Primo N. Lara, Roger Higdon, Nelson Lim et al. · Journal of Clinical Oncology · 2001 · 603 citations

Medicine, Oncology, Cancer Control +13

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma

Thomas J. Semrad, Robert T. OʼDonnell, Ted Wun et al. · Journal of neurosurgery · 2007 · 285 citations

Medicine, Neurosurgery, Oncology +13

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

Sally J. DeNardo, David L. Kukis, Linda A. Kroger et al. · Proceedings of the National Academy of Sciences · 1997 · 109 citations

Medicine, Oncology, Pharmacology +17

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

Carol M. Richman, Sally J. DeNardo, Robert T. OʼDonnell et al. · Clinical Cancer Research · 2005 · 85 citations

Medicine, Oncology, Pharmacology +17

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.

Sally J. DeNardo, Elissa L. Kramer, Robert T. OʼDonnell et al. · PubMed · 1997 · 84 citations

Medicine, Nuclear Medicine, Oncology +17